CDH3 and metastatic malignant neoplasm in the lymph nodes: In terms of staging, levels of P-cadherin were slightly higher in patients with stage III disease with lymph node metastasis compared to those with stage II disease without lymph node metastasis, although the increase was not statistically significant.